References
- 1. Cooper JR, Melcer I. The enzymic oxidation of tryptophan to 5-hydroxytryptophan in the biosynthesis of serotonin. J Pharmacol Exp Ther. 1961; 132:265-8.
- 2. Serretti A, Benedetti F, Zanardi R, Smeraldi E. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Prog Neuropsychopharmacol Biol Psychiatry. 2005; 29:1074-84.10.1016/j.pnpbp.2005.03.013
- 3. Kato T. Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci. 2007; 61:3-19.10.1111/j.1440-1819.2007.01604.x
- 4. Walther DJ, Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol. 2003; 66: 1673-80.10.1016/S0006-2952(03)00556-2
- 5. Zill P, Baghai TC, Zwanzger P, Schule C, Eser D, Rupprecht R, et al. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry. 2004; 9:1030-6.10.1038/sj.mp.4001525
- 6. Gizatullin R, Zaboli G, Jonsson EG, Asberg M, Leopardi R. Haplotype analysis reveals tryptophan hydroxylase (TPH) 1 gene variants associated with major depression. Biol Psychiatry. 2006; 59:295-300.10.1016/j.biopsych.2005.07.034
- 7. Craig SP, Boularand S, Darmon MC, Mallet J, Craig IW. Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3-p14 by in situ hybridization, Cytogenet. Cell Genet.1991; 56:157-9.10.1159/000133075
- 8. Nielsen DA, Virkkunen M, Lappalainen J, Eggert M, Brown GL, Long JC, et al. A tryptophan hydroxylase gene marker for suicidality and alcoholism. Arch Gen Psychiatry. 1998; 55:593-602.10.1001/archpsyc.55.7.593
- 9. New AS, Gelernter J, Yovell Y, Trestman RL, Nielsen DA, Silverman J, et al. Tryptophan hydroxylase genotype is associated with impulsive-aggression measures: a preliminary study. Am J Med Genet. 1998; 81:13-7.10.1002/(SICI)1096-8628(19980207)81:1<13::AID-AJMG3>3.0.CO;2-O
- 10. Pooley EC, Houston K, Hawton K, Harrison PJ. Deliberate self-harm is associated with allelic variation in the tryptophan hydroxylase gene (TPH A779C), but not with polymorphisms in five other serotonergic genes. Psychol Med. 2003; 33:775-83.10.1017/S0033291703007463
- 11. You JS, Hu SY, Chen B, Zhang HG. Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder. Psychiatr Genet. 2005; 15:7-11.10.1097/00041444-200503000-00002
- 12. Hong CJ, Tsai SJ, Wang YC. Association between tryptophan hydroxylase gene polymorphism (A218C) and schizophrenic disorders. Schizophr Res. 2001; 49: 59-63.10.1016/S0920-9964(00)00039-6
- 13. Tan EC, Chan AO, Tan CH, Mahendran R, Wang A, Chua HC. Case-control and linkage disequilibrium studies of the tryptophan hydroxylase gene polymorphisms and major depressive disorder. Psychiatr Genet. 2003; 13:151-4.10.1097/00041444-200309000-00003
- 14. Bellivier F, Leboyer M, Courtet P, Buresi C, Beaufils B, Samolyk D, et al. Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry. 1998; 33:33-7.10.1001/archpsyc.55.1.33
- 15. Turecki G, Zhu Z, Tzenova J, Lesage A, Seguin M, Tousignant M, et al. TPH and suicidal behavior: a study in suicide completers. Mol Psychiatry. 2001; 6: 98-102.10.1038/sj.mp.4000816
- 16. Liu X, Li H, Qin W, He G, Li D, Shen Y, et al. Association of TPH1 with suicidal behaviour and psychiatric disorders in the Chinese population. J Med Genet. 2006; 43: e4.10.1136/jmg.2004.029397
- 17. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21:263-510.1093/bioinformatics/bth457
- 18. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005; 15:97-8.10.1038/sj.cr.7290272
- 19. Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J. How should we use information about HWE in the meta-analyses of genetic association studies? Int J Epidemiol. 2008; 37:136-46.10.1093/ije/dym234
- 20. Nielsen DA, Jenkins GL, Stefanisko KM, Jefferson KK, Goldman D. Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Brain Res Mol Brain Res. 1997; 45:145-8.10.1016/S0169-328X(96)00304-X
- 21. Furlong RA, Ho L, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC. No association of the tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behaviour in major affective disorder. Am J Med Genet.1998; 81: 245-710.1002/(SICI)1096-8628(19980508)81:3<245::AID-AJMG8>3.0.CO;2-V
- 22. Frisch A, Postilnick D, Rockah R, Michaelovsky E, Postilnick S, Birman E, et al. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol Psychiatry. 1999; 4:389-92.10.1038/sj.mp.4000536
- 23. Souery D, Van Gestel S, Massat I, Blairy S, Adolfsson R, Blackwood D, et al. Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: a multicenter association study. Biol Psychiatry. 2001; 49:405-9.10.1016/S0006-3223(00)01043-X
- 24. Fu XY, Ge H, Manley JL. The role of the polypyrimidine stretch at the SV40 early pre-mRNA 3' splice site in alternative splicing. EMBO J. 1998; 7:809-17.
- 25. Rotondo A, Schuebel K, Bergen A, Aragon R, Virkkunen M, Linnoila M, et al. Identification of four variants in the tryptophan hydroxylase promoter and association to behavior. Mol Psychiatry.1999; 4:360-8.10.1038/sj.mp.4000578
- 26. Sun HS, Fann CS, Lane HY, Chang YT, Chang CJ, Liu YL, et al. A functional polymorphism in the promoter region of the tryptophan hydroxylase gene is associated with alcohol dependence in one aboriginal group in Taiwan. Alcohol Clin Exp Res. 2005; 29:1-7.10.1097/01.ALC.0000150635.51934.6D
- 27. Du L, Bakish D, Hrdina PD. Tryptophan hydroxylase gene 218A/C polymorphism is associated with somatic anxiety in major depressive disorder. J Affect Disord. 2001; 65:37-44.10.1016/S0165-0327(00)00274-3
- 28. Tsai SJ, Hong CJ, Wang YC. Tryptophan hydroxylase gene polymorphism (A218C) and suicidal behaviors. Neuroreport.1999; 10:3773-5.10.1097/00001756-199912160-00010
- 29. Mann JJ, Malone KM, Nielsen DA, Goldman D, Erdos J, Gelernter J. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients. Am J Psychiatry. 1997; 154:1451-3.10.1176/ajp.154.10.1451
- 30. Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E. Tryptophan hydroxylase gene and major psychoses. Psychiatry Res. 2001; 103:79-86.10.1016/S0165-1781(01)00269-4
- 31. Wang HC, Yeh TL, Chang HH, Gean PW, Chi MH, Yang YK, et al. TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients. Psychopharmacology (Berl). 2011; 213:773-9.10.1007/s00213-010-2034-120945066
- 32. Department of Statistics, 2001. Population and housing census of Malaysia 2000, Malaysia, Kuala Lumpur.
- 33. Anttila S, Huuhka K, Huuhka M, Rontu R, Mattila KM, Leinonen E, et al. Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression. J Neural Transm. 2007; 114:461-8.10.1007/s00702-006-0583-617066254
- 34. Jokela M, Raikkonen K, Lehtimaki T, Rontu R, Keltikangas-Jarvinen L. Tryptophan hydroxylase 1 gene (TPH1) moderates the influence of social support on depressive symptoms in adults. J Affect Disord. 2007; 100:191-7.10.1016/j.jad.2006.10.016
- 35. Porter RJ, Mulder RT, Joyce PR, Miller AL, Kennedy M. Tryptophan hydroxylase gene (TPH1) and peripheral tryptophan levels in depression. J Affect Disord.2008; 109:209-12.10.1016/j.jad.2007.11.010
- 36. Jonsson EG, Goldman D, Spurlock G, Gustavsson JP, Nielsen DA, Linnoila M, et al. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur Arch Psychiatry Clin Neurosci. 1997; 247:297-302.10.1007/BF02922258
- 37. Jammy Suzana AA, Norlaili MT, Sherina MS. The prevalence of depessive disorders among adult patients attending primary care clinics. Malaysian J Psychiatry. 2005; 13:25-9.
- 38. Stefulj J, Kubat M, Balija M, Skavic J, Jernej B. Variability of the tryptophan hydroxylase gene: study in victims of violent suicide. Psychiatry Res. 2005; 134:67-73.10.1016/j.psychres.2004.04.011
- 39. Ham BJ, Lee BC, Paik JW, Kang RH, Choi MJ, Choi IG, et al. Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31:104-7.10.1016/j.pnpbp.2006.08.001
- 40. Serretti A, Zanardi R, Cusin C,Rossini D, Lorenzi C, Smeraldi E. Tryptophan hydroxylase gene associated with paroxetine antidepressant activity. Eur Neuropsychopharmacol, 2001; 11:375-80.10.1016/S0924-977X(01)00113-4
- 41. Viikki M, Kampman O, Illi A, Setl-Soikkeli E, Anttila S, Huuhka M, et al. TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response. Neurosci Lett. 2010; 468:80-4.10.1016/j.neulet.2009.10.06919874868
- 42. Wang HC, Yeh TL, Chang HH, Gean PW, Chi MH, Yang YK, et al. TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients. Psychopharmacology (Berl). 2011; 213:773-9.10.1007/s00213-010-2034-120945066
- 43 Ham BJ, Lee MS, Lee HJ, Kang RH, Han CS, Choi MJ, et al. No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population. Psychiatr Genet. 2005; 15:299-301.10.1097/00041444-200512000-0001416314762
- 44. Hong CJ, Chen TJ, Yu YW, Tsai SJ. Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J. 2006; 6:27-33.10.1038/sj.tpj.650034016302021